Proteome-wide Identification of Ubiquitin Interactions Using UbIA-MS
Overview
Authors
Affiliations
Ubiquitin-binding proteins play an important role in eukaryotes by translating differently linked polyubiquitin chains into proper cellular responses. Current knowledge about ubiquitin-binding proteins and ubiquitin linkage-selective interactions is mostly based on case-by-case studies. We have recently reported a method called ubiquitin interactor affinity enrichment-mass spectrometry (UbIA-MS), which enables comprehensive identification of ubiquitin interactors for all ubiquitin linkages from crude cell lysates. One major strength of UbIA-MS is the fact that ubiquitin interactors are enriched from crude cell lysates, in which proteins are present at endogenous levels, contain biologically relevant post-translational modifications (PTMs) and are assembled in native protein complexes. In addition, UbIA-MS uses chemically synthesized nonhydrolyzable diubiquitin, which mimics native diubiquitin and is inert to cleavage by endogenous deubiquitinases (DUBs). Here, we present a detailed protocol for UbIA-MS that proceeds in five stages: (i) chemical synthesis of ubiquitin precursors and click chemistry for the generation of biotinylated nonhydrolyzable diubiquitin baits, (ii) in vitro affinity purification of ubiquitin interactors, (iii) on-bead interactor digestion, (iv) liquid chromatography (LC)-MS/MS analysis and (v) data analysis to identify differentially enriched proteins. The computational analysis tools are freely available as an open-source R software package, including a graphical interface. Typically, UbIA-MS allows the identification of dozens to hundreds of ubiquitin interactors from any type of cell lysate, and can be used to study cell type or stimulus-dependent ubiquitin interactions. The nonhydrolyzable diubiquitin synthesis can be completed in 3 weeks, followed by ubiquitin interactor enrichment and identification, which can be completed within another 2 weeks.
Morderer D, Wren M, Liu F, Kouri N, Maistrenko A, Khalil B Mol Neurodegener. 2025; 20(1):32.
PMID: 40082954 PMC: 11905455. DOI: 10.1186/s13024-025-00817-0.
In Situ and In Silico Methods for Senescence Identification in Human Liver Diseases.
Evangelou K, Belogiannis K, Pantelis P, Liaropoulos G, Skaltsas D, Sakellariou S Methods Mol Biol. 2025; 2906:1-20.
PMID: 40082347 DOI: 10.1007/978-1-0716-4426-3_1.
Spatial top-down proteomics for the functional characterization of human kidney.
Zemaitis K, Fulcher J, Kumar R, Degnan D, Lewis L, Liao Y Clin Proteomics. 2025; 22(1):9.
PMID: 40045235 PMC: 11881370. DOI: 10.1186/s12014-025-09531-x.
CTDP1 and RPB7 stabilize Pol II and permit reinitiation.
Zheng H, Xu Q, Ji D, Yang B, Ji X Nat Commun. 2025; 16(1):2161.
PMID: 40038320 PMC: 11880454. DOI: 10.1038/s41467-025-57513-2.
The Surface Proteome of Bovine Unsexed and Sexed Spermatozoa.
Pinto-Pinho P, Quelhas J, Impens F, Dufour S, Van Haver D, Lopes G Animals (Basel). 2025; 15(4).
PMID: 40002966 PMC: 11852025. DOI: 10.3390/ani15040484.